Brief: Taimed Biologics Says It Has Terminated Theratechnologies' Exclusive Rights Of The Company's Product Trogarzo In Europe
01/11/2022 07:45
Nov 1 (Reuters) - Taimed Biologics 4147.TWO :
* SAYS IT HAS TERMINATED THERATECHNOLOGIES' TH.TO
EXCLUSIVE
DISTRIBUTION RIGHTS OF THE COMPANY'S PRODUCT TROGARZO IN EUROPE
* SAYS THERATECHNOLOGIES CONTINUES TO HOLD THE EXCUSIVE
DISTRIBTUTION RIGHTS OF TROGARZO IN NORTH AMERICA
Source text for Eikon: ID:nMOP98pCx1
Further company coverage: 4147.TWO
(Reporting by Hong Kong newsroom)
((donny.kwok@thomsonreuters.com; +852 3462 7745;))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process